Health
Precision Medicine Takes Center Stage in GI Cancer – Cancer Network
In order to properly utilize cancer therapies for personalized care, adequate molecular testing must be performed in patients who are eligible for these therapies,…
The recent advances in immunotherapy have revolutionized cancer care and ushered in an era of true precision medicine. But to best utilize these extraordinary therapies, oncologists must be able to recognize specific biomarkers and oncologic drivers associated with an individual patients cancer diagnosis. This is true, in particular, for oncologists specializing in the care of gastrointestinal (GI) cancers.
In this issue of ONCOLOGY®, we spoke with John L. Marshall, MD, director of the Ruesch Center…
-
Noosa News23 hours agoMeasles alert issued across popular south-east attractions
-
General23 hours agoSector warns Coalition’s plan to limit overseas students ‘straight out of Trump’s playbook’
-
Noosa News24 hours agoHomicide investigation launched into stabbing death of 39-year-old Brisbane man at Bowen Hills apartment
-
General20 hours agoChinese spies, ports and Donald | Scam of the Week